PRODUCT CLASSIFICATION
Melanocortin Receptor Agonists
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Deus Medical
LAB TEST
Refer to Document
WAREHOUSE
EU Warehouse 2
ACTIVE SUBSTANCE
Bremelanotide
Discover the transformative power of PT-141 (Bremelanotide), a leading peptide renowned for its ability to enhance libido in both men and women. This innovative compound is synthetically produced yet has been clinically proven to be completely safe. PT-141 is especially beneficial for men dealing with erectile dysfunction and women experiencing sexual disorders.
Beyond its primary function, research has uncovered additional advantages of Bremelanotide, including its capacity to stimulate melanin production, leading to a natural tanning effect. As ongoing laboratory studies explore its potential, the versatility of this peptide continues to expand.
Unlike traditional medications such as Viagra and Cialis that focus on blood vessel dilation, Bremelanotide directly influences sexual desire through its unique active ingredients. Users can expect:
- Enhanced sexual potency
- Increased sexual desire
- Prolonged duration of intercourse
- Heightened sensitivity
To achieve optimal results, it is crucial to adhere to the recommended instructions for PT-141.
Application and Dosage of PT-141
For effective results, a subcutaneous dose of 0.3 milligrams is recommended initially. This starting dose allows you to assess how your body responds to the active components. Adjustments can be made if necessary, with an ideal single administration range between 0.5 and 1.5 milligrams.
Users typically experience the first signs of Bremelanotide's effects within a couple of hours post-administration, reaching peak effectiveness after 3-4 hours. The benefits can last an impressive 8-10 hours.
Side Effects and Contraindications
Clinical studies have validated that Bremelanotide meets all specified characteristics and effectively serves its purpose. However, some participants reported elevated blood pressure, leading to the discontinuation of certain trials. User experiences also indicate that an overdose may cause fluctuations in blood pressure, potentially resulting in hypertension. Mild local reactions, such as redness at the injection site, can occur but typically resolve quickly and are not considered serious.